Skip to main content
Clinical Trials/NCT01321021
NCT01321021CompletedNot Applicable

Influence of Losartan and Diphenhydramine on Emotional and Cognitive Functions in Healthy Human Subjects

Prof. Dominique de Quervain, MD1 site in 1 country80 target enrollmentStarted: March 2011Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
80
Locations
1
Primary Endpoint
Primary Outcome Measures

Study Overview

Brief Summary

This project aims at identifying novel pharmacological targets for the treatment of memory disorders.

Detailed Description

To investigate the effects of the histamine H1 receptor antagonist diphenhydramine and the angiotensin II receptor antagonist losartan on emotional and cognitive functions in healthy human subjects.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Basic Science
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • native or fluent German-speaking
  • BMI between 19 and 27 kg/m2
  • able and willing to give written informed consent and comply with the requirements of the study protocol
  • willing to donate saliva sample for DNA-analysis
  • female: willing to perform a pregnancy test at the beginning of both test visits

Exclusion Criteria

  • acute or chronic psychiatric or somatic disorder
  • pathological ECG
  • known hypersensitivity to the IMP under investigation (losartan, diphenhydramine)
  • hypotension (RR < 110/70 mmHg)
  • bradycardia (< 50 bpm)
  • pregnancy, breast-feeding
  • long-term medication within last 3 months (oral contraceptives are disregarded)
  • smoking (> 3 cigarettes per day)
  • concurrent participation in another study
  • participation in one of our previous studies using the same memory tests
  • inability to read and understand the participant's information

Arms & Interventions

Losartan, Diphenhydramine, Placebo

Experimental

placebo controlled crossover study with two arms: Losartan, Diphenhydramine

Intervention: Losartan, Diphenhydramine, Placebo (Drug)

Outcomes

Primary Outcomes

Primary Outcome Measures

Time Frame: during cognitive testing at study days

Memory functions

Secondary Outcomes

  • Secondary Outcome Measures(during cognitive testing at study days)

Investigators

Sponsor
Prof. Dominique de Quervain, MD
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Prof. Dominique de Quervain, MD

Prof., MD

University of Basel

Study Sites (1)

Loading locations...

Similar Trials